Victory in New Hampshire Prescription Datamining Case!

The 1st Circuit Court of Appeals today issued a decision upholding New Hampshire's Prescription Confidentiality Act. The Act sought to prohibit the practice of “datamining” for the purpose of pharmaceutical marketing: pharmacies sell doctors’ individual…Read More

PAL posts documents re: Pfizer manipulation of Neurontin studies

Today on the Prescription Access Litigation blog: http://blog.prescriptionaccess.org/?p=304 A major story broke today in the New York Times, Wall Street Journal and Boston Globe about Pfizer’s alleged manipulation of studies of its epilepsy drug…Read More

PAL: Consumers eligible for payments from $125 Million pharmaceutical class action settlement

Consumers: You may be eligible for payment from $125 million prescription drug settlement September 12th, 2008 Back in March, we reported that 11 defendants in the massive In re Pharmaceutical Industry Average Wholesale Price Litigation case had agreed to…Read More

2 exciting PAL Announcements!

Prescription Access Litigation is proud to announce: 1. A proposed settlement has been reached in the Norvir class action. This lawsuit alleged that Abbott Laboratories violated federal antitrust law when it raised the price of its HIV/AIDS drug by 400%.…Read More

Action Alert: Tell the FDA what you think about drug ads.

Tell the FDA what you think about drug ads. Goal: 50,000 signatures! https://secure.consumersunion.org/site/SPageServer?pagename=Rx_Drug_Ads_Petition Drug ads aim to convince us to buy the newest and most expensive prescription drugs. They tell us the "good…Read More

11 Drug Companies Agree to Pay $125 million to Settle Price Inflation Allegations

In This E-mail: • 11 Drug Companies Agree to Pay $125 million to Settle Price Inflation Allegations • Make a Difference in 90 Seconds: Tell Us Your Story 11 Drug Companies Agree to Pay $125 million to Settle Price Inflation Allegations A $125 million…Read More
to comment